Short answer · Medically reviewed summary · Last updated: 2026-05-08
Fetal Valproate Syndrome, often referred to as Valproate Embryopathy, is a congenital condition caused by prenatal exposure to the anti-epileptic medication valproic acid. While Fetal Valproate Syndrome is the most common clinical term, medical records may also use terms like Valproate Spectrum Disorder to reflect the wide range of neurodevelopmental and physical effects observed in affected individuals. What are the common synonyms for Fetal Valproate Syndrome? Because Fetal Valproate Syndrome was identified after the widespread use of valproate, researchers have used various terms to describe the clinical presentation.
Fetal Valproate Syndrome synonyms
Other names for Fetal Valproate Syndrome: synonyms, acronyms and related terms used by doctors and patients.
Fetal Valproate Syndrome, often referred to as Valproate Embryopathy, is a congenital condition caused by prenatal exposure to the anti-epileptic medication valproic acid. While Fetal Valproate Syndrome is the most common clinical term, medical records may also use terms like Valproate Spectrum Disorder to reflect the wide range of neurodevelopmental and physical effects observed in affected individuals.
What are the common synonyms for Fetal Valproate Syndrome?
Because Fetal Valproate Syndrome was identified after the widespread use of valproate, researchers have used various terms to describe the clinical presentation. Common synonyms include Valproate Embryopathy, Valproic Acid Embryopathy, and Fetal Valproate Spectrum Disorder. In some older medical literature, you may encounter the term "Valproate Teratogenicity," though this refers more to the mechanism of harm rather than the clinical diagnosis of Fetal Valproate Syndrome itself.
Why are there multiple names for this condition?
The variety of names for Fetal Valproate Syndrome stems from the evolution of our understanding of the condition. Initially, clinicians focused on specific physical malformations, leading to the "syndrome" designation. As we learned that the condition impacts neurodevelopment and behavior in the absence of severe physical defects, the term "spectrum disorder" gained popularity to better encompass the full clinical experience of those within the DiseaseMaps community and beyond.
How is the condition classified in medical databases?
Official classification systems provide clarity for clinicians and patients. Key designations include:
- Orphanet: Listed under ORPHA:88574 as Valproic acid embryopathy.
- ICD-10/11: Often coded under Q86.8 (Congenital malformation syndromes due to known exogenous causes).
- OMIM: Frequently cross-referenced in clinical genetics databases as a recognized teratogenic syndrome.
Which name is preferred by medical professionals today?
While Fetal Valproate Syndrome remains the most widely recognized term in clinical practice, many specialists now prefer "Valproate Spectrum Disorder" to acknowledge the highly variable nature of the condition. Regardless of the specific label, the focus remains on the specific neurodevelopmental and physical support required by the patient.
Next steps
- Consult with a clinical geneticist or a neurologist familiar with teratogenic exposures.
- Review your medical records to see how your specific diagnosis is coded.
- Connect with others who have Fetal Valproate Syndrome via the DiseaseMaps.org community to share experiences and coping strategies.
Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of a qualified healthcare provider with any questions regarding a medical condition.
References
- NIH Genetic and Rare Diseases Information Center (GARD): Fetal Valproate Syndrome.
- Orphanet: Valproic acid embryopathy (ORPHA:88574).
- OMIM (Online Mendelian Inheritance in Man): Entry on Teratogenic effects of Valproic Acid.
- European Medicines Agency (EMA): Guidance on Valproate use in pregnancy.
